Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Rheum Dis 2004; 63: 974–981.

    Article  CAS  Google Scholar 

  2. Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54: 3750–3760.

    Article  Google Scholar 

  3. Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, Mayes MD et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004; 31: 2513–2516.

    PubMed  Google Scholar 

  4. Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis. Resolution in dermal fibrosis. Arthritis Rheum 2006; 54: 1982–1986.

    Article  Google Scholar 

  5. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y . Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603–610.

    Article  CAS  Google Scholar 

  6. Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S et al. In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. Blood 2000; 96: 2419–2425.

    CAS  PubMed  Google Scholar 

  7. Wang B, Yamamoto Y, El-Badri NS, Good RA . Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc Nat Acad Sci USA 1999; 96: 3012–3016.

    Article  CAS  Google Scholar 

  8. Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.

    Article  CAS  Google Scholar 

  9. Marmont AM, Gualandi F, van Lint MT, Bacigalupo A . Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: 399–402.

    Article  CAS  Google Scholar 

  10. Burt RK, Oyama Y, Verda L, Quigley K, Brush M, Yaung K et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50: 2466–2470.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R K Burt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loh, Y., Oyama, Y., Statkute, L. et al. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?. Bone Marrow Transplant 39, 435–437 (2007). https://doi.org/10.1038/sj.bmt.1705611

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705611

This article is cited by

Search

Quick links